Eli Lilly Jardiance — Revenue decreased by 19.9% to $768.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 35.9%, from $1.20B to $768.60M. Over 4 years (FY 2021 to FY 2025), Jardiance — Revenue shows an upward trend with a 23.2% CAGR.
lly_segment_jardiance_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $356.50M | $390.40M | $431.90M | $419.40M | $461.00M | $573.30M | $612.30M | $577.50M | $668.30M | $700.80M | $798.10M | $686.50M | $769.60M | $686.40M | $1.20B | $1.01B | $690.00M | $959.00M | $768.60M |
| QoQ Change | — | +9.5% | +10.6% | -2.9% | +9.9% | +24.4% | +6.8% | -5.7% | +15.7% | +4.9% | +13.9% | -14.0% | +12.1% | -10.8% | +74.6% | -15.4% | -32.0% | +39.0% | -19.9% |
| YoY Change | — | — | — | — | +29.3% | +46.8% | +41.8% | +37.7% | +45.0% | +22.2% | +30.3% | +18.9% | +15.2% | -2.1% | +50.2% | +47.8% | -10.3% | +39.7% | -35.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.